Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Tenofovir DF in HIV-Infected Children
NCT00528957Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Dec 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00528957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528957.